TULOVI

Serial Number 98504382
Registration 7822177
700

Registration Progress

Application Filed
Apr 17, 2024
Under Examination
Approved for Publication
Apr 22, 2025
Published for Opposition
Apr 22, 2025
Registered
Jun 10, 2025

Trademark Image

TULOVI

Basic Information

Serial Number
98504382
Registration Number
7822177
Filing Date
April 17, 2024
Registration Date
June 10, 2025
Published for Opposition
April 22, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jun 10, 2025
Registration
Registered
Classes
005

Rights Holder

KVR Pharmaceuticals Inc.

03
Address
11 Millbank Avenue
Toronto, Ontario M5P1S2
CA

Ownership History

KVR Pharmaceuticals Inc.

Original Applicant
03
Toronto, Ontario CA

KVR Pharmaceuticals Inc.

Owner at Publication
03
Toronto, Ontario CA

KVR Pharmaceuticals Inc.

Original Registrant
03
Toronto, Ontario CA

Legal Representation

Attorney
Liane L. Churney

USPTO Deadlines

Next Deadline
2138 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-06-10)
Due Date
June 10, 2031
Grace Period Ends
December 10, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

21 events
Date Code Type Description Documents
Jun 10, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jun 10, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Apr 22, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 22, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 16, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 28, 2025 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 27, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 27, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 27, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 28, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jan 28, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jan 28, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jan 27, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 27, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jan 27, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 30, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Oct 30, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Oct 30, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Oct 30, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 17, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 17, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome, hemorrhagic diseases and disorders, endocrine diseases and disorders, namely, growth disorders, thyroid disorders, genitourinary diseases and disorders, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases, oncological diseases and disorders, hepatological diseases and disorders, and hormonal diseases and disorders

Classification

International Classes
005